China has released the first comprehensive update to its National Drug Catalogue for Basic Medical Insurance, Work-Related Injury Insurance and Maternity Insurance since it was first published in 2000. More
China has reformatted its drug manufacturing permits and associated documentation in a bid to unify the look and content of its administrative licences. One of the most notable changes is the enhanced prominence of contact numbers for the day-to-day supervisory body and the relevant complaints hotline, a move designed to improve oversight and boost consumer confidence. More
New measures aimed at boosting the development of community-based family services have been jointly-unveiled by the Ministry of Finance and four other government bodies. With the focus very much on elderly care, child care and other domestic services, the incentives on offer – as detailed in Circular No. 76  – are largely related to preferential tax and fee arrangements. More
The National Medical Products Administration (NMPA) recently issued a circular, stating that local medical products’ administrations must conduct inspections of medical devices in accordance with Appendix I and Appendix II of the National Plan for Product Sampling Inspection of Medical Devices... More
The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service is seeking input from interested parties by 5 August on a proposed new rule regarding the regulation of certain genetically engineered organisms. More
In the 19th century, Hong Kong made an indelible mark on the world of medicine – it was here that the lifecycle of one of humanity’s greatest scourges, malaria, was discovered, opening the way to control and cure.